VNTA OTC
Ventana Biotech, Inc.
1W: -35.5%
1M: -35.5%
3M: -49.8%
YTD: -14.4%
1Y: +45.6%
3Y: -94.7%
5Y: -96.0%
$0.03
-0.00 (-5.11%)
Weekly Expected Move ±33.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$62K
+82.9% ▲
Total Liabilities
$114K
+7.7% ▲
Shareholders Equity
-$52K
+27.5% ▲
Cash & Investments
$62K
+82.9% ▲
Total Debt
$110K
+4.3% ▲
Net Debt
$48K
-33.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2008 | FY2023 | FY2024 |
|---|---|---|---|
| — Assets — | |||
| Cash | $0 | $34K | $62K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $0 | $34K | $62K |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 |
| Total Current Assets | $3K | $34K | $62K |
| Property, Plant & Equip. | $0 | $0 | $0 |
| Goodwill & Intangibles | $57K | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 |
| Total Non-Current Assets | $57K | $0 | $0 |
| Total Assets | $59K | $34K | $62K |
| — Liabilities — | |||
| Accounts Payable | $0 | $300 | $4K |
| Short-Term Debt | $141K | $105K | $110K |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $1K | $0 | $0 |
| Total Current Liabilities | $142K | $106K | $114K |
| Long-Term Debt | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 |
| Total Liabilities | $142K | $106K | $114K |
| — Equity — | |||
| Common Stock | $55K | $108K | $108K |
| Retained Earnings | -$238K | -$254K | -$234K |
| Accumulated OCI | $0 | $0 | $0 |
| Total Stockholders Equity | -$83K | -$72K | -$52K |
| Total Liabilities & Equity | $59K | $34K | $62K |
| — Key Metrics — | |||
| Total Debt | $141K | $105K | $110K |
| Net Debt | $141K | $71K | $48K |
| Total Investments | $0 | $0 | $0 |